Oscar Health, Inc. Hits New 52-Week High of $29.81

Oscar Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 29.81 on June 16, 2026. This achievement marks a notable increase from its 52-week low of USD 10.69, showcasing a remarkable performance over the past year. The stock has demonstrated a robust annual return of 39.25%, significantly outperforming the S&P 500, which recorded a return of 24.5% during the same period. As a small-cap company in the healthcare services industry, Oscar Health, Inc. has a market capitalization of USD 3,320 million. Despite facing challenges reflected in its negative operating profits and margins, the stock's recent performance indicates a strong recovery trajectory. The company's price-to-book ratio stands at 3.40, further illustrating its valuation in the market. While the company has experienced nine consecutive quarters of negative results, the substantial rise in stock price highlights a shift in market dynamics. Investors and market observers will be keen to monitor how Oscar Health navigates its financial landscape moving forward.